-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Atara Biotherapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from Q3 2022 to Q2 2024.
- Atara Biotherapeutics, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $46.9M, a 35.2% decline year-over-year.
- Atara Biotherapeutics, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $241M.
- Atara Biotherapeutics, Inc. annual Costs and Expenses for 2023 was $285M, a 17.3% decline from 2022.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)